Press Releases

HOLON, Israel, Aug. 5, 2019 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today reported financ

REHOVOT, Israel, Aug. 5, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN) (the "Company"), a regenerative medicine company, announced today that it is developing 3D bioprinted implants for regeneration of breast tissue and has successfully produced first prototypes. The implants will be comprised of CollPlant's proprietary type I recombinant human collagen and

INDIANAPOLIS, Aug. 5, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Emgality® (galcanezumab-gnlm) met the primary and all key secondary outcomes in CONQUER, a Phase 3 study evaluating the efficacy and safety of Emgality in the preventive treatment of chronic and episodic migraine in patients with documented previous

NEW YORK, Aug. 5, 2019 /PRNewswire/ -- Renowned Johns Hopkins surgeon, researcher and policy expert Martin (Marty) Makary, MD, MPH, will serve FAIR Health as its Policy Advisor. In that role, Dr. Makary will help inform the research and policy-related initiatives of FAIR Health, a national, independent nonprofit

TEL AVIV, Israel, Aug. 5, 2019 /PRNewswire/ -- VGS - Vascular Graft Solutions Ltd. announced today it has received CE Mark Approval for the FRAME FR, a novel solution for repair and stabilization of high flow and aneurysmal arteriovenous fistulas in hemodialysis patients.

BETHESDA, Md., Aug. 5, 2019 /PRNewswire/ -- In the coming year, the nation's Community Health Centers will serve more people than ever with patient numbers projected to reach 29 million – that's one in 12 Americans, according to estimates from the National Association of Community Health Centers (NACHC).  The new numbers were released as communities acro

NEW YORK, Aug. 5, 2019 /PRNewswire/ -- Anytime Fitness, the world's fastest-growing fitness franchise, recently announced plans to introduce over 25 new gyms in targeted areas through

TOKYO and LONDON, Aug. 5, 2019 /PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) announces that it has entered into a strategic multi-target partnership with Takeda Pharmaceutical Company Limited ("Takeda")1, to discover, develop and commercialize novel molecules, including small molecules and biologics,

JOENSUU, Finland, Aug. 5, 2019 /PRNewswire/ -- Eating rye comes with a variety of health benefits. A new study from the University of Eastern Finland now shows that both lactic acid bacteria and gut bacteria contribute to the health benefits of rye. Published in Microbiome, the study used a metabolomics approach to analyse metabol

TOKYO, Aug. 5, 2019 /PRNewswire/ -- Nissui Pharmaceutical Co., Ltd., based in Tokyo, is pleased to announce that @BactLAB(TM), an application that uses Amazon Web Service (AWS) Cloud and artificial intelligence (AI) technologies to enable quick and easy counting of bacterial colonies, is now ava